FDA Inspection
Guilin China Resources Tianhe Pharmaceutical Co., Ltd.Guilin China Resources Tianhe Pharmaceutical Co., Ltd. – FDA Inspection, Mar 28, 2025
Record Details
This FDA Inspection record concerns Guilin China Resources Tianhe Pharmaceutical Co., Ltd., with an inspection on March 28, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 28, 2025
- Product Type
- Drugs
View Company Profile
ID · 8e55f59b-b213-4c68-9f30-c9810bec4d5e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1268372
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Guilin China Resources Tianhe Pharmaceutical Co., Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 11, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Guilin China Resources Tianhe Pharmaceutical Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.